相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases
Gerald Brock et al.
JOURNAL OF SEXUAL MEDICINE (2016)
Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction
Soon Hyun Park et al.
ASIAN JOURNAL OF ANDROLOGY (2015)
Treatment Satisfaction of Men and Partners Following Switch from On-Demand Phosphodiesterase Type 5 Inhibitor Therapy to Tadalafil 5 mg Once Daily
Patrick R. Burns et al.
JOURNAL OF SEXUAL MEDICINE (2015)
A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis
Milo A. Puhan et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis
JinQiu Yuan et al.
EUROPEAN UROLOGY (2013)
Multicriteria benefit-risk assessment using network meta-analysis
Gert van Valkenhoef et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
Georgia Salanti et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
A Therapeutic Confirmatory Study to Assess the Safety and Efficacy of Zydena® (Udenafil) for the Treatment of Erectile Dysfunction in Male Patients with Diabetes Mellitus
Du Geon Moon et al.
JOURNAL OF SEXUAL MEDICINE (2011)
Nitric Oxide Synthesis Is Reduced in Subjects With Type 2 Diabetes and Nephropathy
Paolo Tessari et al.
DIABETES (2010)
Efficacy and Safety of Oral Mirodenafil in the Treatment of Erectile Dysfunction in Diabetic Men in Korea: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Hyun Jun Park et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction
D. Hatzichristou et al.
DIABETIC MEDICINE (2008)
Erectile dysfunction among men with diabetes is strongly associated with premature ejaculation and reduced libido
Lasantha S. Malavige et al.
JOURNAL OF SEXUAL MEDICINE (2008)
Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunction
Dan Ziegler et al.
JOURNAL OF SEXUAL MEDICINE (2006)
Erectile dysfunction - An observable marker of diabetes mellitus? A large national epidemiological study
Peter Sun et al.
JOURNAL OF UROLOGY (2006)
Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction:: Results of a multicenter, randomized, double-blind, placebo-controlled trial
Hartmut Porst et al.
EUROPEAN UROLOGY (2006)
Vardenal 20-mg demonstrated superior efcacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction
Nobuhisa Ishii et al.
INTERNATIONAL JOURNAL OF UROLOGY (2006)
Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat
L Vignozzi et al.
JOURNAL OF SEXUAL MEDICINE (2006)
Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: Scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries
J Buvat et al.
JOURNAL OF SEXUAL MEDICINE (2006)
Efficacy and safety of sildenafil in men with serotonergic anti-depressant-associated erectile dysfunction: Results from a randomized, double-blind, placebo-controlled trial.
M Fava et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Prevalence of erectile dysfunction in Korean men with Type 2 diabetes mellitus
NH Cho et al.
DIABETIC MEDICINE (2006)
The prevalence of erectile dysfunction in the primary care setting - Importance of risk factors for diabetes and vascular disease
SA Grover et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Predictors and prevalence of erectile dysfunction in a racially diverse population
CS Saigal et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple anti hypertensives
H van Ahlen et al.
JOURNAL OF SEXUAL MEDICINE (2005)
Prevalence and risk factors for erectile dysfunction in Japanese diabetics
H Sasaki et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: Lack of tachyphylaxis
D Behr-Roussel et al.
EUROPEAN UROLOGY (2005)
Oral sildenafil in the treatment of erectile dysfunction in diabetic men - A randomized double-blind and placebo-controlled study
MR Safarinejad
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2004)
Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials
V Fonseca et al.
DIABETOLOGIA (2004)
Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes - A multicenter double-blind placebo-controlled fixed-dose study
I Goldstein et al.
DIABETES CARE (2003)
Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes - Results of a randomized controlled trial
BGA Stuckey et al.
DIABETES CARE (2003)
Efficacy and safety of sildenafil in men with type 2 diabetes mellitus and erectile dysfunction
F Escobar-Jiménez
MEDICINA CLINICA (2002)
Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus
AJM Boulton et al.
DIABETOLOGIA (2001)
Neuropathy is a major contributing factor to diabetic erectile dysfunction
MJ Hecht et al.
NEUROLOGICAL RESEARCH (2001)
Drug therapy: Erectile dysfunction.
TF Lue
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
